I’ve never done one of these before, but I’m gonna make a thread of tweets explaining the key findings, and more importantly what our paper doesn’t show. 1/n
First and foremost, there is no conclusive evidence at present that any clade of SARS-CoV-2 is associated with increased mortality or severity of the disease. 2/n
Our earlier bioRxiv study reported an uncategorized cluster of SARS-CoV-2 genomes which was responsible for the initial outbreak in India (Late Feb to April). We called it the I/A3i clade. 3/n
Viruses of I/A3i clade are identified by specific variations at 4 different places in their genomes. One of them is in RDRP - the viral enzyme needed for making more copies of viral RNA. 4/n
The RDRP variant is predicted to be bad for virus. If it is so, we expect A3i clade to slowly disappear, as other clades prevail. The updated analysis shows this - proportion of A3i clade reduced to ~18% now, compared to 41% when bioRxiv paper was submitted (early June). 5/n
The only place where we continue to see more of I/A3i clade is in Delhi. However, more data collected from recent time points would be required to see if the trend continues or Delhi also follows other states. 6/n
So, if not A3i, what is present in India? Almost 70% of isolates belong to the A2a clade, the globally prevalent clade. A2a, also known as the G clade or 20A/B/C, is the clade which carries the (in)famous D614G mutation in the Spike protein. 7/n
D614G mutation is shown to be more infectious in nature. Infectivity, not severity or death. Hence, it makes sense that viruses carrying this mutation will ultimately be over-represented everywhere, including India. This is good news because.. 8/n
If a vaccine/drug targeting this mutation is developed anywhere in the world, it will work with the same efficiency even here. 9/n
Finally, just to drive the point home, no clade at present is shown to be associated with increased severity or morbidity of COVID19. 10/10
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Lineages with #N440K are NOT the dominant ones in the second wave of #Covid19inIndia. While N440K was a indeed mutation of concern in South India during and after the first wave, current data shows that it is essentially replaced by new VoCs such as #B1617 and #B117
When comparing the data from MH, in MH we can see that the increase in B.1.617 is seen in Feb rather than Mar 2021, and again we observe a reduction in proportion of lineages with N440K.
This coincides well with the second waves seen in the respective states. In MH, the second wave started almost a month and half earlier compared to the 4 southern states, along with the explosion of B.1.617 at the expense of lineages with the mutation N440K.
So much misinformation and confusion about the circulating #SARSCoV2 variants in India. Leaving aside that the names are scientifically inaccurate, #B1618 ("Bengal variant") is NOT the #tripleMutant. I will try to summarize the basics in this thread.
(1/n)
B.1.617: characterized by more than 15 mutations, it got dubbed the "double mutant" because of two spike mutations, L452R and E484Q, which were mutations of concern because of their immune escape properties, and possible high infectivity.
What's more, there are several sequences of B.1.617 which don't have the E484Q mutation, now sampled in India and elsewhere, which means it's not even the OG "double mutant" anymore.